Study provides new insights into resistance to immune checkpoint inhibitors

Drug testing approach uncovers effective combination for treating small cell lung cancer
12 April 2021
Study reveals neural stem cells age rapidly
12 April 2021

Study provides new insights into resistance to immune checkpoint inhibitors

New research by Yale Cancer Center shows insights into modeling resistance to immune checkpoint inhibitors, a form of cancer immunotherapy. The study was presented today at the American Association of Cancer Research (AACR) virtual annual meeting.

Comments are closed.